Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Influenza vaccines generated by reverse genetics.

K Subbarao1, J M Katz

  • 1Influenza Branch, Centers for Disease Control and Prevention, Mailstop G-16, 1600 Clifton Road, Atlanta, GA 30333, USA.

Current Topics in Microbiology and Immunology
|August 10, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Platform Trial In COVID-19 priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity, and safety of licensed COVID-19 vaccinations administered as a second booster in BNT162b2 primed individuals aged 18-<50 and 50-<70 years old.

The Journal of infection·2024
Same author

The Platform Trial In COVID-19 Priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity, and safety of different COVID-19 vaccinations administered as a second booster (fourth dose) in AZD1222 primed individuals aged 50-<70 years old.

The Journal of infection·2024
Same author

Heparin-mediated PCR interference in SARS-CoV-2 assays and subsequent reversal with heparinase I.

Journal of virological methods·2024
Same author

Author Correction: A placental model of SARS-CoV-2 infection reveals ACE2-dependent susceptibility and differentiation impairment in syncytiotrophoblasts.

Nature cell biology·2023
Same author

A placental model of SARS-CoV-2 infection reveals ACE2-dependent susceptibility and differentiation impairment in syncytiotrophoblasts.

Nature cell biology·2023
Same author

Quantifying the reduction of airborne infectious viral load using a ventilated patient hood.

The Journal of hospital infection·2023

Annual influenza epidemics necessitate updated vaccines due to viral antigenic variation. Reverse genetics offers a powerful new method for rapidly generating safe and effective influenza vaccines, including for pandemic strains.

Area of Science:

  • Virology
  • Immunology
  • Vaccinology

Background:

  • Influenza viruses cause significant annual epidemics and occasional pandemics.
  • Vaccination is the primary control strategy, but requires frequent reformulation due to viral antigenic drift.
  • Traditional vaccine strain generation relies on reassortment, a method limited by the virus's segmented genome.

Purpose of the Study:

  • To highlight advancements in influenza vaccine development using reverse genetics.
  • To discuss the potential of reverse genetics for rapid strain generation and novel vaccine strategies.
  • To explore the application of reverse genetics in developing pandemic and improved seasonal influenza vaccines.

Main Methods:

  • Utilizing reverse genetics to generate influenza viruses entirely from cloned plasmid DNA.

Related Experiment Videos

  • Employing cotransfection of cells with plasmids encoding viral RNA and mRNA.
  • Exploring directed mutation of internal genes for attenuated vaccine candidates.
  • Modifying genes to remove virulence determinants from highly pathogenic avian influenza strains.

    • Main Results:

    • Reverse genetics enables the complete de novo generation of influenza viruses from plasmid DNA.
    • This technology facilitates the rapid and routine production of strains for inactivated and live attenuated vaccines.
    • Potential for novel vaccine strategies, including genetically engineered attenuated donors.
    • Application in developing pandemic influenza vaccines by attenuating virulent strains.

    Conclusions:

    • Reverse genetics represents a significant technological advancement for influenza vaccine development.
    • The technology promises faster, safer, and more effective influenza vaccines, including for pandemic preparedness.
    • Future influenza prevention and control efforts will heavily rely on the application of reverse genetics.